Skip to main content

Table 1 Patients’ characteristics

From: The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

 

Overall

Young-old group

Old-old group

P valuea

Number of patients (N/%)

50

22 (44.0)

28 (56.0)

-

Age (years)

75.7 ± 7.6

68.7 (2.7)

81.1 (5.3)

< 0.001

Prostate volume (mL)

33.7 ± 8.6

33.5 (7.6)

33.7 (9.5)

0.961

α1-adrenergic receptor blocker

    

 Silodosin (N/%)

26 (52.0)

13 (59.1)

13 (46.4)

 

 Naftopidil

15 (30.0)

5 (22.7)

10 (35.7)

 

 Tamsulosin

8 (16.0)

3 (13.6)

5 (17.9)

 

 Urapidil

1 (2.0)

1 (4.5)

0 (0)

 
  1. Data are shown as mean ± standard deviation
  2. aDifference between the young-old group and old-old group